Evaluating Welltower: Insights From 9 Financial Analysts

What the experts are saying about Welltower WELL in recent reports within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 1 4 4 0 0
Last 30D 0 1 0 0 0
1M Ago 0 0 2 0 0
2M Ago 1 2 0 0 0
3M Ago 0 1 2 0 0

Within the last quarter, 9 analysts provided 12-month price targets for Welltower. The average target is $93.22, with a high estimate of $101.00 and a low estimate of $83.00.

Below is a summary of how these 9 analysts rated Welltower over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

price target chart

A notable 3.91% increase in the average price target has occurred over the past month.

Exploring Analyst Ratings: An In-Depth Overview

Explore the sentiments of financial experts and analysts through a comprehensive breakdown of their recent evaluations for Welltower. Our Ratings Table below offers a detailed overview of the actions taken by key analysts, their current ratings, and price targets. Understanding how these experts perceive the company can provide valuable insights into potential market trends and investor sentiment.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Michael Mueller JP Morgan Raises Overweight $99.00 $92.00
Michael Carroll RBC Capital Raises Sector Perform $97.00 $92.00
Steve Sakwa Evercore ISI Group Raises In-Line $89.00 $86.00
Todd Stender Wells Fargo Raises Overweight $95.00 $93.00
Jonathan Hughes Raymond James Raises Strong Buy $101.00 $95.00
Todd Thomas Keybanc Raises Overweight $90.00 $80.00
Michael Mueller JP Morgan Announces Neutral $90.00 -
Richard Anderson Wedbush Announces Neutral $83.00 -
Jonathan Hughes Raymond James Raises Outperform $95.00 $90.00

Key Insights:

  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Welltower. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Welltower compared to the broader market.
  • Price Targets: Analysts predict movements in price targets, offering estimates for Welltower's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

Capture valuable insights into Welltower's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Welltower analyst ratings.

About Welltower

Welltower owns a diversified healthcare portfolio of over 2,000 in-place properties spread across the senior housing, medical office, and skilled nursing/post-acute care sectors. The portfolio includes over 100 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.

Key Indicators: Welltower's Financial Health

Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.

Positive Revenue Trend: Examining Welltower's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 12.77% as of 30 September, 2023, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 7.67%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): Welltower's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 0.58%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): Welltower's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.31%, the company showcases efficient use of assets and strong financial health.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.71.

The Core of Analyst Ratings: What Every Investor Should Know

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!